The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty

Skedgel, Chris, Goeree, Ron, Pleasance, Sue, Thompson, Kara, O'brien, Bernie and Anderson, David (2007) The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. The Journal of Bone and Joint Surgery (American), 89 (4). pp. 819-828. ISSN 0021-9355

Full text not available from this repository. (Request a copy)

Abstract

Although the risk of thromboembolism after total hip arthroplasty continues beyond hospital discharge, the cost-effectiveness of extending prophylaxis beyond hospitalization is unclear. We compared the cost-effectiveness of an extended duration of antithrombotic prophylaxis following total hip arthroplasty, with use of low-molecular-weight heparin or warfarin administered for twenty-eight days beyond hospital discharge, in terms of incremental cost per quality-adjusted life year gained.

Item Type: Article
Uncontrolled Keywords: anticoagulants,arthroplasty, replacement, hip,cost-benefit analysis,heparin, low-molecular-weight,humans,thromboembolism,time factors,warfarin
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: Pure Connector
Date Deposited: 04 Feb 2015 12:42
Last Modified: 21 Apr 2020 23:48
URI: https://ueaeprints.uea.ac.uk/id/eprint/51941
DOI: 10.2106/JBJS.F.00092

Actions (login required)

View Item View Item